• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5

Article

Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.

The American Heart Association 2020 Scientific Sessions continue on Monday and Tuesday, November 16 and 17, and include late-breaking clinical trial results from VITAL-AF, MSTOPS, RHAPSODY, MyROAD, and more.

To help your advance planning, click through the agenda for each session, below. For Friday, Saturday, and Sunday's sessions, click here.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women / Image credit: ©harunyigit/AdobeStock

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

April 24th 2024
Article

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Untreated, New-Onset Hypertension Tied to Higher Risk of Uterine Fibroids in Women / Image credit: ©AGPhotography/AdobeStock

Untreated, New-Onset Hypertension Tied to Higher Risk of Uterine Fibroids in Women

April 19th 2024
Article

Women with new-onset HTN faced a 45% greater risk of newly self-reported fibroids and those with untreated HTN had a 19% greater risk, according to a new study.

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

October 29th 2020
Podcast

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Individuals with CVD Consume More Daily Sodium than Recommended, According to New Data / Image credit: ©Vasiliy/AdobeStock

Individuals with CVD Consume More Daily Sodium than Recommended, According to New Data

April 9th 2024
Article

ACC.24: Adults with a history of CVD consumed more than double the recommended daily sodium amount, reported researchers.

"Inclisiran First" Strategy Leads to 60% Reduction in LDL-C vs 7% for Usual Care: VICTORIAN-INITIATE Findings

"Inclisiran First" Strategy Leads to 60% Reduction in LDL-C vs 7% for Usual Care: VICTORION-INITIATE Findings

April 6th 2024
Article

ACC. 24: A structured, systematic approach to lipid-lowering therapy in secondary prevention is needed to ensure targets are met and met swiftly, said researchers.

© 2024 MJH Life Sciences

All rights reserved.